ArticleInternational journal of general medicine2021
Trend Analysis and Forecasting the Spread of COVID-19 Pandemic in Ethiopia Using Box-Jenkins Modeling Procedure.
Article in International journal of general medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 20 citations in OpenAlex.
- Comparison of Chest Computed Tomography (CT) Imaging Patterns and Severity among COVID-19 Patients during the First and Fourth Waves in Addis Ababa, Ethiopia.Radiology research and practice · 2023Article
- Spatio-temporal predictions of COVID-19 test positivity in Uppsala County, Sweden: a comparative approach.Scientific reports · 2022Article
- SARIMA Model Forecasting Performance of the COVID-19 Daily Statistics in Thailand during the Omicron Variant Epidemic.Healthcare (Basel, Switzerland) · 2022Article
- Article
- Short-Term Forecasting of Daily Confirmed COVID-19 Cases in Malaysia Using RF-SSA Model.Frontiers in public health · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionCOVID-19, which causes severe acute respiratory syndrome, is spreading rapidly across the world, and the severity of this pandemic is rising in Ethiopia. The main objective of the study was to analyze the trend and forecast the spread of COVID-19 and to develop an appropriate statistical forecast model. METHODOLOGY: Data on the daily spread between 13 March, 2020 and 31 August 2020 were collected for the development of the autoregressive integrated moving average (ARIMA) model. Stationarity testing, parameter testing and model diagnosis were performed. In addition, candidate models were obtained using autocorrelation function (ACF) and partial autocorrelation functions (PACF). Finally, the fitting, selection and prediction accuracy of the ARIMA models was evaluated using the RMSE and MAPE model selection criteria.
resultsA total of 51,910 confirmed COVID-19 cases were reported from 13 March to 31 August 2020. The total recovered and death rates as of 31 August 2020 were 37.2% and 1.57%, respectively, with a high level of increase after the mid of August, 2020. In this study, ARIMA (0, 1, 5) and ARIMA (2, 1, 3) were finally confirmed as the optimal model for confirmed and recovered COVID-19 cases, respectively, based on lowest RMSE, MAPE and BIC values. The ARIMA model was also used to identify the COVID-19 trend and showed an increasing pattern on a daily basis in the number of confirmed and recovered cases. In addition, the 60-day forecast showed a steep upward trend in confirmed cases and recovered cases of COVID-19 in Ethiopia.
conclusionForecasts show that confirmed and recovered COVID-19 cases in Ethiopia will increase on a daily basis for the next 60 days. The findings can be used as a decision-making tool to implement health interventions and reduce the spread of COVID-19 infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.